Wordt geladen...

Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation

INTRODUCTION: Topical ophthalmic formulations of corticosteroids are commonly used to treat a variety of ocular diseases and conditions that have an inflammatory component. The purpose of this study was to evaluate the effect of the mucus-penetrating particle (MPP) technology on the pharmacokinetic...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ophthalmol Ther
Hoofdauteurs: Schopf, Lisa, Enlow, Elizabeth, Popov, Alexey, Bourassa, James, Chen, Hongming
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Healthcare 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254862/
https://ncbi.nlm.nih.gov/pubmed/25134493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-014-0021-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!